{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["VDR genetic polymorphisms", "molecular biology methods", "preeclampsia"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34574039", "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "17"}], "Language": ["eng"], "ELocationID": ["1698", "10.3390/diagnostics11091698"], "Journal": {"ISSN": "2075-4418", "JournalIssue": {"Volume": "11", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "17"}}, "Title": "Diagnostics (Basel, Switzerland)", "ISOAbbreviation": "Diagnostics (Basel)"}, "ArticleTitle": "The Significance of <i>VDR</i> Genetic Polymorphisms in the Etiology of Preeclampsia in Pregnant Polish Women.", "Abstract": {"AbstractText": ["For the first time in the Polish population, we aimed to investigate associations between the <i>VDR</i> gene single-nucleotide polymorphisms (SNPs) <i>BsmI</i> (rs15444410), <i>ApaI</i> (rs7975232), <i>FokI</i> (rs19735810), and <i>TaqI</i> (rs731236) and the development of preeclampsia (PE). A case-control study surveyed 122 preeclamptic and 184 normotensive pregnant women. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was performed to examine the maternal <i>VDR FokI</i>, <i>BsmI</i>, <i>TaqI</i>, and <i>ApaI</i> polymorphisms. The <i>VDR BsmI</i><i>AA</i> homozygous genotype was statistically significantly more frequent in preeclamptic women compared to the control group (<i>p</i> = 0.0263), which was also associated with a 2-fold increased risk of PE (OR = 2.06, <i>p</i> = 0.012). A correlation between the <i>VDR BsmI</i> polymorphism with systolic and diastolic blood hypertension was noted. Furthermore, 3-marker haplotype <i>CTA</i> (<i>TaqI/ApaI/BsmI</i>) was associated with significantly higher systolic (<i>p</i> = 0.0075) and diastolic (<i>p</i> = 0.0072) blood pressure. Association and haplotype analysis indicated that the <i>VDR BsmI A</i> allele could play a significant role in the PE pathomechanism and hence could be a risk factor for PE development in pregnant Polish women. These results indicate the importance of the <i>VDR BsmI</i> polymorphism and reveal that this variant is closely associated with a higher predisposition to hypertension."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Perinatology and Women's Disease, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Magie\u0142da-Stola", "ForeName": "Justyna", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Perinatology and Women's Disease, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Kurzawi\u0144ska", "ForeName": "Gra\u017cyna", "Initials": "G"}, {"Identifier": ["0000-0003-2305-3116"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Institute of Natural Fibres and Medicinal Plants, Wojska Polskiego 71b, 60-630 Poznan, Poland."}], "LastName": "O\u017carowski", "ForeName": "Marcin", "Initials": "M"}, {"Identifier": ["0000-0001-6599-9204"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chair and Department of Medical Microbiology, Poznan University of Medical Sciences, Wieniawskiego 3, 61-712 Poznan, Poland."}], "LastName": "Karpi\u0144ski", "ForeName": "Tomasz M", "Initials": "TM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Perinatology and Women's Disease, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Drews", "ForeName": "Krzysztof", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Perinatology and Women's Disease, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}, {"Identifier": [], "Affiliation": "Laboratory of Molecular Biology in Division of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Polna 33, 60-535 Poznan, Poland."}], "LastName": "Seremak-Mrozikiewicz", "ForeName": "Agnieszka", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Diagnostics (Basel)", "NlmUniqueID": "101658402", "ISSNLinking": "2075-4418"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hutcheon J.A., Lisonkova S., Joseph K.S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract. Res. Clin. Obstet. Gynaecol. 2011;25:391\u2013403. doi: 10.1016/j.bpobgyn.2011.01.006.", "ArticleIdList": ["10.1016/j.bpobgyn.2011.01.006", "21333604"]}, {"Citation": "Teliga-Czajkowska J., Czajkowski K., Januszewicz A., Sieradzki J., Wi\u0119cek A. Nadci\u015bnienie t\u0119tnicze i diabetologia w pytaniach i odpowiedziach. In: Szczeklik A., Gajewski P., editors. Nadci\u015bnienie T\u0119tnicze a Ci\u0105\u017ca. Wyd. 1; Krak\u00f3w, Poland: 2009. pp. 207\u2013221. Medycyna Praktyczna."}, {"Citation": "Szczepaniak-Chiche\u0142 L., Br\u0119borowicz G., Tykarski A. Leczenie nadci\u015bnienia t\u0119tniczego u kobiet w ci\u0105\u017cy. Nadci\u015bnienie T\u0119tnicze. 2006;10:83\u201398."}, {"Citation": "Bokslag A., van Weissenbruch M., Mol B.W., de Groot C.J.M. Preeclampsia; short and long-term consequences for mother and neonate. Early Hum. Dev. 2016;102:47\u201350. doi: 10.1016/j.earlhumdev.2016.09.007.", "ArticleIdList": ["10.1016/j.earlhumdev.2016.09.007", "27659865"]}, {"Citation": "McKinney D., Boyd H., Langager A., Oswald M., Pfister A., Warshak C.R. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia. Am. J. Obstet. Gynecol. 2016;214:395. doi: 10.1016/j.ajog.2015.12.050.", "ArticleIdList": ["10.1016/j.ajog.2015.12.050", "26767794"]}, {"Citation": "Fox R., Kitt J., Leeson P., Aye C.Y.L., Lewandowski A.J. Preeclampsia: Risk factors, diagnosis, management and the cardiovascular impact on the offspring. J. Clin. Med. 2019;8:1625. doi: 10.3390/jcm8101625.", "ArticleIdList": ["10.3390/jcm8101625", "PMC6832549", "31590294"]}, {"Citation": "O\u017carowski M., Karpi\u0144ski T.M., Szulc M., Wielgus K., Kujawski R., Wolski H., Seremak-Mrozikiewicz A. Plant phenolics and extracts in animal models of preeclampsia and clinical trials\u2014Review of perspectives for novel therapies. Pharmaceuticals. 2021;14:269. doi: 10.3390/ph14030269.", "ArticleIdList": ["10.3390/ph14030269", "PMC8000132", "33809556"]}, {"Citation": "Knabl J., Vattai A., Ye Y., Jueckstock J., Hutter S., Kainer F., Mahner S., Jeschke U. Role of placental VDR expression and function in common late pregnancy disorders. Int. J. Mol. Sci. 2017;18:2340. doi: 10.3390/ijms18112340.", "ArticleIdList": ["10.3390/ijms18112340", "PMC5713309", "29113124"]}, {"Citation": "Rana S., Lemoine E., Granger J.P., Karumanchi S.A. Preeclampsia: Pathophysiology, challenges, and perspectives. Circ Res. 2019;124:1094\u20131112. doi: 10.1161/CIRCRESAHA.118.313276.", "ArticleIdList": ["10.1161/CIRCRESAHA.118.313276", "30920918"]}, {"Citation": "Jena M.K., Sharma N.R., Petitt M., Maulik D., Nayak N.R. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 2020;10:953. doi: 10.3390/biom10060953.", "ArticleIdList": ["10.3390/biom10060953", "PMC7357118", "32599856"]}, {"Citation": "Tsuprykov O., Chen X., Hocher C.F., Skoblo R., Lianghong Y., Hocher B. Why should we measure free 25(OH) vitamin D? J. Steroid Biochem. Mol. Biol. 2018;180:87\u2013104. doi: 10.1016/j.jsbmb.2017.11.014.", "ArticleIdList": ["10.1016/j.jsbmb.2017.11.014", "29217467"]}, {"Citation": "Hollis B.W. Assessment of vitamin D status and definition of normal circulating range of 25-hydroxyvitamin D. Curr. Opin. Endocrinol. Diabetes. Obes. 2008;15:489\u2013494. doi: 10.1097/MED.0b013e328317ca6c.", "ArticleIdList": ["10.1097/MED.0b013e328317ca6c", "18971676"]}, {"Citation": "Holick M.F. Vitamin D: A D-lightful health perspective. Nutr. Rev. 2008;66:182\u2013194. doi: 10.1111/j.1753-4887.2008.00104.x.", "ArticleIdList": ["10.1111/j.1753-4887.2008.00104.x", "18844847"]}, {"Citation": "Lensmeyer G., Poquette M., Wiebe D., Binkley N. The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum. J. Clin. Endocrinol. Metab. 2012;97:163\u2013168. doi: 10.1210/jc.2011-0584.", "ArticleIdList": ["10.1210/jc.2011-0584", "22013102"]}, {"Citation": "Specker B. Vitamin D requirements during pregnancy. Am. J. Clin. Nutr. 2004;80:1740\u20131747. doi: 10.1093/ajcn/80.6.1740S.", "ArticleIdList": ["10.1093/ajcn/80.6.1740S", "15585798"]}, {"Citation": "Williams A.F. Vitamin D In pregnancy: An old problem still to be solved? Arch. Dis. Child. 2007;92:740\u2013741. doi: 10.1136/adc.2007.120774.", "ArticleIdList": ["10.1136/adc.2007.120774", "PMC2084015", "17715434"]}, {"Citation": "Hollis B.W., Wagner C.L. Vitamin D and pregnancy: Skeletal effects, nonskeletal effects, and birth outcomes. Calcif. Tissue Int. 2013;92:128\u2013139. doi: 10.1007/s00223-012-9607-4.", "ArticleIdList": ["10.1007/s00223-012-9607-4", "22623177"]}, {"Citation": "Colonese F., Lagan\u00e0 A.S., Colonese E., Sofo V., Salmeri F.M., Granese R., Triolo O. The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: An overview on a hot topic. Biomed. Res. Int. 2015;2015:986281. doi: 10.1155/2015/986281.", "ArticleIdList": ["10.1155/2015/986281", "PMC4426767", "26000308"]}, {"Citation": "Wagner C.L., Hollis B.W. The Implications of Vitamin D Status during Pregnancy on Mother and her Developing Child. Front. Endocrinol. 2018;9:500. doi: 10.3389/fendo.2018.00500.", "ArticleIdList": ["10.3389/fendo.2018.00500", "PMC6127214", "30233496"]}, {"Citation": "Powe C.E., Levine R.J., Karumanchi S.A. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123:2856\u20132869. doi: 10.1161/CIRCULATIONAHA.109.853127.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.109.853127", "PMC3148781", "21690502"]}, {"Citation": "Widmer R.J., Lerman A. Endothelial dysfunction and cardiovascular disease. Glob. Cardiol. Sci. Pract. 2014;3:291\u2013308. doi: 10.5339/gcsp.2014.43.", "ArticleIdList": ["10.5339/gcsp.2014.43", "PMC4352682", "25780786"]}, {"Citation": "Konukoglu D., Uzun H. Endothelial dysfunction and hypertension. Adv. Exp. Med. Biol. 2016;956:511\u2013540.", "ArticleIdList": ["28035582"]}, {"Citation": "Liberis A., Stanulov G., Ali E.C., Hassan A., Pagalos A., Kontomanolis E.N. Pre-eclampsia and the vascular endothelial growth factor: A new aspect. Clin. Exp. Obstet. Gynecol. 2016;43:9\u201313.", "ArticleIdList": ["27048010"]}, {"Citation": "Guney G., Taskin M.I., Tokmak A. Increase of circulating inflammatory molecules in preeclampsia, an update. Eur. Cytokine Netw. 2020;31:18\u201331. doi: 10.1684/ecn.2020.0443.", "ArticleIdList": ["10.1684/ecn.2020.0443", "32540805"]}, {"Citation": "Harmon A.C., Cornelius D.C., Amaral L.M., Faulkner J.L., Cunningham M.W., Wallace K., LaMarca B. The role of inflammation in the pathology of preeclampsia. Clin. Sci. 2016;130:409\u2013419. doi: 10.1042/CS20150702.", "ArticleIdList": ["10.1042/CS20150702", "PMC5484393", "26846579"]}, {"Citation": "Barrera D., D\u00edaz L., Noyola-Mart\u00ednez N., Halhali A. Vitamin D and inflammatory cytokines in healthy and preeclamptic pregnancies. Nutrients. 2015;7:6465\u20136490. doi: 10.3390/nu7085293.", "ArticleIdList": ["10.3390/nu7085293", "PMC4555132", "26247971"]}, {"Citation": "Chan S.Y., Susarla R., Canovas D., Vasilopoulou E., Ohizua O., McCabe C.J., Hewison M., Kilby M.D. Vitamin D promotes human extravillous trophoblast invasion in vitro. Placenta. 2015;36:403\u2013409. doi: 10.1016/j.placenta.2014.12.021.", "ArticleIdList": ["10.1016/j.placenta.2014.12.021", "25596923"]}, {"Citation": "Du H., Daftary G.S., Lalwani S.I., Taylor H.S. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol. Endocrinol. 2005;19:2222\u20132233. doi: 10.1210/me.2004-0336.", "ArticleIdList": ["10.1210/me.2004-0336", "15905361"]}, {"Citation": "Boonstra A., Barrat F.J., Crain C., Heath V.L., Savelkoul H.F., O\u2019Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 2001;167:4974\u20134980. doi: 10.4049/jimmunol.167.9.4974.", "ArticleIdList": ["10.4049/jimmunol.167.9.4974", "11673504"]}, {"Citation": "Card\u00fas A., Parisi E., Gallego C., Aldea M., Fern\u00e1ndez E., Valdivielso J.M. 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. Kidney Int. 2006;69:1377\u20131384. doi: 10.1038/sj.ki.5000304.", "ArticleIdList": ["10.1038/sj.ki.5000304", "16557229"]}, {"Citation": "Barrera D., Noyola-Mart\u00ednez N., Avila E., Halhali A., Larrea F., D\u00edaz L. Calcitriol inhibits interleukin-10 expression in cultured human trophoblasts under normal and inflammatory conditions. Cytokine. 2012;57:316\u2013321. doi: 10.1016/j.cyto.2011.11.020.", "ArticleIdList": ["10.1016/j.cyto.2011.11.020", "22182686"]}, {"Citation": "Xu J., Gu Y., Lewis D.F., Cooper D.B., McCathran C.E., Wang Y. Downregulation of vitamin D receptor and miR-126-3p expression contributes to increased endothelial inflammatory response in preeclampsia. Am. J. Reprod. Immunol. 2019;82:e13172. doi: 10.1111/aji.13172.", "ArticleIdList": ["10.1111/aji.13172", "31323164"]}, {"Citation": "Li Y.C. Vitamin D regulation of the renin-angiotensin system. J. Cell Biochem. 2003;88:327\u2013331. doi: 10.1002/jcb.10343.", "ArticleIdList": ["10.1002/jcb.10343", "12520534"]}, {"Citation": "Akbari S., Khodadadi B., Ahmadi S.A.Y., Abbaszadeh S., Shahsavar F. Association of vitamin D level and vitamin D deficiency with risk of preeclampsia: A systematic review and updated meta-analysis. Taiwan J. Obstet. Gynecol. 2018;57:241\u2013247. doi: 10.1016/j.tjog.2018.02.013.", "ArticleIdList": ["10.1016/j.tjog.2018.02.013", "29673668"]}, {"Citation": "Lumbers E.R., Delforce S.J., Arthurs A.L., Pringle K.G. Causes and Consequences of the Dysregulated Maternal Renin-Angiotensin System in Preeclampsia. Front. Endocrinol. 2019;10:563. doi: 10.3389/fendo.2019.00563.", "ArticleIdList": ["10.3389/fendo.2019.00563", "PMC6746881", "31551925"]}, {"Citation": "Baker A.R., McDonnellm D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O\u2019Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 1988;85:3294\u20133298. doi: 10.1073/pnas.85.10.3294.", "ArticleIdList": ["10.1073/pnas.85.10.3294", "PMC280195", "2835767"]}, {"Citation": "Uitterlinden A.G., Fang Y., Van Meurs J.B.J., Pols H.A.P., Van Leeuwen J.P. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338:143\u2013156. doi: 10.1016/j.gene.2004.05.014.", "ArticleIdList": ["10.1016/j.gene.2004.05.014", "15315818"]}, {"Citation": "Arai H., Miyamoto K., Taketani Y., Yamamoto H., Iemori Y., Morita K., Tonai T., Nishisho T., Mori S., Takeda E. A vitamin D receptor gene polymorphism in the translation initiation codon: Effect on protein activity and relation to bone mineral density in Japanese women. J. Bone Miner. Res. 1997;12:915\u2013921. doi: 10.1359/jbmr.1997.12.6.915.", "ArticleIdList": ["10.1359/jbmr.1997.12.6.915", "9169350"]}, {"Citation": "ACOG. ACOG practice bulletin no. 202: Gestational hypertension and preeclampsia. Obs. Gynecol. 2019;133:e1\u2013e25. doi: 10.1097/AOG.0000000000003018.", "ArticleIdList": ["10.1097/AOG.0000000000003018", "30575675"]}, {"Citation": "Farajian-Mashhadi F., Eskandari F., Rezaei M., Eskandari F., Najafi D., Teimoori B., Moradi-Sharbabak M., Salimi S. The possible role of maternal and placental vitamin D receptor polymorphisms and haplotypes in pathogenesis of preeclampsia. Clin. Exp. Hypertens. 2020;42:171\u2013176. doi: 10.1080/10641963.2019.1601203.", "ArticleIdList": ["10.1080/10641963.2019.1601203", "31006279"]}, {"Citation": "Barchitta M., Maugeri A., La Rosa M.C., San Lio R.M., Favara G., Panella M., Cianci A., Agodi A. The effect of vitamin D receptor gene (VDR) polymorphisms on adverse pregnancy outcomes\u2014Including preterm birth (PTB and small for gestational age. Nutrients. 2018;10:1172. doi: 10.3390/nu10091172.", "ArticleIdList": ["10.3390/nu10091172", "PMC6164379", "30150529"]}, {"Citation": "Pani M.A., Knapp M., Donner H., Braun J., Baur M.P., Usadel K.H., Badenhoop K. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes. 2000;49:504\u2013507. doi: 10.2337/diabetes.49.3.504.", "ArticleIdList": ["10.2337/diabetes.49.3.504", "10868975"]}, {"Citation": "Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., Sambrook P.N., Eisman J.A. Prediction of bone density from vitamin D receptor alleles. Nature. 1994;367:284\u2013287. doi: 10.1038/367284a0.", "ArticleIdList": ["10.1038/367284a0", "8161378"]}, {"Citation": "Harris S.S., Eccleshall T.R., Gross C., Dawson-Hughes B., Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J. Bone Miner. Res. 1997;12:1043\u20131048. doi: 10.1359/jbmr.1997.12.7.1043.", "ArticleIdList": ["10.1359/jbmr.1997.12.7.1043", "9200003"]}, {"Citation": "R Core Team . A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2019."}, {"Citation": "Gonz\u00e1lez J.R., Armengol L., Sol\u00e9 X., Guin\u00f3 E., Mercader J.M., Estivill X., Moreno V. SNPassoc: An R package to perform whole genome association studies. Bioinformatics. 2007;23:644\u2013645. doi: 10.1093/bioinformatics/btm025.", "ArticleIdList": ["10.1093/bioinformatics/btm025", "17267436"]}, {"Citation": "Wang L., Ma J., Manson J.E., Buring J.E., Gaziano J.M., Sesso H.D. A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur. J. Nutr. 2013;52:1771\u20131779. doi: 10.1007/s00394-012-0480-8.", "ArticleIdList": ["10.1007/s00394-012-0480-8", "PMC3609910", "23262750"]}, {"Citation": "Valdivielso J.M., Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin. Chim. Acta. 2006;371:1\u201312. doi: 10.1016/j.cca.2006.02.016.", "ArticleIdList": ["10.1016/j.cca.2006.02.016", "16563362"]}, {"Citation": "Zhu Y.B., Li Z.Q., Ding N., Yi H.L. The association between vitamin D receptor gene polymorphism and susceptibility to hypertension: A meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 2019;23:9066\u20139074. doi: 10.26355/eurrev_201910_19309.", "ArticleIdList": ["10.26355/eurrev_201910_19309", "31696497"]}, {"Citation": "Liu J., Dai Q., Li W., Guo Y., Dai A., Wang Y., Deng M., Tang Z., She L., Chen X., et al. Association of vitamin D receptor gene polymorphisms with gestational diabetes mellitus-a case control study in Wuhan, China. BMC Pregnancy Childbirth. 2021;21:142. doi: 10.1186/s12884-021-03621-y.", "ArticleIdList": ["10.1186/s12884-021-03621-y", "PMC7887796", "33596840"]}, {"Citation": "Zhou Q., Wen S., Liu M., Zhang S., Jin X., Liu A. Association between Gene Polymorphisms of Vitamin D Receptor and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health. 2020;18:205. doi: 10.3390/ijerph18010205.", "ArticleIdList": ["10.3390/ijerph18010205", "PMC7794905", "33383970"]}, {"Citation": "Apayd\u0131n M., Beysel S., Eyerci N., Pinarli F.A., Ulubay M., Kizilgul M., Ozdemir O., Caliskan M., Cakal E. The VDR gene FokI polymorphism is associated with gestational diabetes mellitus in Turkish women. BMC Med. Genet. 2019;20:82. doi: 10.1186/s12881-019-0820-0.", "ArticleIdList": ["10.1186/s12881-019-0820-0", "PMC6524275", "31096931"]}, {"Citation": "Krpina M.G., Bari\u0161i\u0107 A., Peterlin A., Tul N., Ostoji\u0107 S., Peterlin B., Pereza N. Vitamin D receptor polymorphisms in spontaneous preterm birth: A case-control study. Croat. Med. J. 2020;61:338\u2013345. doi: 10.3325/cmj.2020.61.338.", "ArticleIdList": ["10.3325/cmj.2020.61.338", "PMC7480758", "32881432"]}, {"Citation": "Bari\u0161i\u0107 A., Pereza N., Hod\u017ei\u0107 A., Krpina M.G., Ostoji\u0107 S., Peterlin B. Genetic variation in the maternal vitamin D receptor FokI gene as a risk factor for recurrent pregnancy loss. J. Matern. Fetal. Neonatal. Med. 2021;34:2221\u20132226. doi: 10.1080/14767058.2019.1660768.", "ArticleIdList": ["10.1080/14767058.2019.1660768", "31446814"]}, {"Citation": "Wolski H., Kurzawi\u0144ska G., O\u017carowski M., Mrozikiewicz A.E., Drews K., Karpi\u0144ski T.M., Bogacz A., Seremak-Mrozikiewicz A. Vitamin D receptor gene polymorphisms and haplotypes in the etiology of recurrent miscarriages. Sci. Rep. 2021;11:4646. doi: 10.1038/s41598-021-84317-3.", "ArticleIdList": ["10.1038/s41598-021-84317-3", "PMC7907056", "33633340"]}, {"Citation": "Wolski H., Kurzawinska G., Ozarowski M., Drews K., Barlik M., Piatek K., Malewski Z., Mrozikiewicz A.E., Magielda-Stola J., Kolanowska D., et al. FokI vitamin D receptor polymorphism as a protective factor in intrahepatic cholestasis of pregnancy. Ginekol. Pol. 2020;91:719\u2013725. doi: 10.5603/GP.a2020.0135.", "ArticleIdList": ["10.5603/GP.a2020.0135", "33447990"]}, {"Citation": "Rezavand N., Tabarok S., Rahimi Z., Vaisi-Raygani A., Mohammadi E., Rahimi Z. The effect of VDR gene polymorphisms and vitamin D level on blood pressure, risk of preeclampsia, gestational age, and body mass index. J. Cell. Biochem. 2019;120:6441\u20136448. doi: 10.1002/jcb.27934.", "ArticleIdList": ["10.1002/jcb.27934", "30417411"]}, {"Citation": "Zhan Y., Liu M., You Y., Zhang Y., Wang J., Wang X., Liu S., Liu X. Genetic variations in the vitamin-D receptor (VDR) gene in preeclampsia patients in the Chinese Han population. Hypertens. Res. 2015;38:513\u2013517. doi: 10.1038/hr.2015.29.", "ArticleIdList": ["10.1038/hr.2015.29", "25787039"]}, {"Citation": "Baca K.M., Govil M., Zmuda J.M., Simhan H.N., Marazita M.L., Bodnar L.M. Vitamin D metabolic loci and preeclampsia risk in multi-ethnic pregnant women. Physiol. Rep. 2018;6:e13468. doi: 10.14814/phy2.13468.", "ArticleIdList": ["10.14814/phy2.13468", "PMC5789712", "29380949"]}, {"Citation": "Rezende V.B., Sandrim V.C., Palei A.C., Machado L., Cavalli R.C., Duarte G., Tanus-Santos J.E. Vitamin D receptor polymorphisms in hypertensive disorders of pregnancy. Mol. Biol. Rep. 2012;39:10903\u201310906. doi: 10.1007/s11033-012-1988-y.", "ArticleIdList": ["10.1007/s11033-012-1988-y", "23053984"]}, {"Citation": "Ghorbani Z., Shakiba M., Rezavand N., Rahimi Z., Vaisi-Raygani A., Rahimi Z., Shakiba E. Gene variants and haplotypes of Vitamin D biosynthesis, transport, and function in preeclampsia. Hypertens. Pregnancy. 2021;40:1\u20138. doi: 10.1080/10641955.2020.1849274.", "ArticleIdList": ["10.1080/10641955.2020.1849274", "33305962"]}, {"Citation": "Caccamo D., Cannata A., Ricca S., Catalano L.M., Montalto A.F., Alibrandi A., Ercoli A., Granese R. Role of Vitamin-D Receptor (VDR) single nucleotide polymorphisms in gestational hypertension development: A case-control study. PLoS ONE. 2020;15:e0239407. doi: 10.1371/journal.pone.0239407.", "ArticleIdList": ["10.1371/journal.pone.0239407", "PMC7665745", "33186385"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "14"}, {"Year": "2021", "Month": "9", "Day": "9"}, {"Year": "2021", "Month": "9", "Day": "13"}, {"Year": "2021", "Month": "9", "Day": "28", "Hour": "1", "Minute": "10"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "17"}], "PublicationStatus": "epublish", "ArticleIdList": ["34574039", "PMC8465173", "10.3390/diagnostics11091698", "diagnostics11091698"]}}], "PubmedBookArticle": []}